Dr. Chris Chen, CEO, WuXi Biologics (Shanghai) Co., Ltd.

Dr. Chris Chen, CEO, WuXi Biologics (Shanghai) Co., Ltd.


The International Society for Pharmaceutical Engineering (ISPE) announced Dr. Chris Chen, CEO, WuXi Biologics (Shanghai) Co., Ltd., as a newly confirmed and final keynote speaker for their 2018 Annual Meeting & Expo, taking place in Philadelphia, Pennsylvania, November 4–7.

At WuXi, Dr. Chen has built a world-class open-access integrated monoclonal antibodies (mAb) discovery, development, and manufacturing platform serving a full spectrum of global companies. Under his leadership, WuXi has assembled one of the largest biologics development teams and is currently building the largest disposable-bioreactor based state-of-the-art commercial manufacturing facility totaling 30,000L bioreactor capacity in the world.

In Dr. Chen’s keynote presentation, he will speak on advancements in biologics, sharing insights on how WuXi Biologics has forged new paths for the development, manufacturing, and delivery of cutting-edge therapies.

The 2018 ISPE Annual Meeting & Expo delivers a broad spectrum of technical education for multiple levels of expertise. The event features six tracks that include more than 50 education sessions and five technical workshops on equipment reliability, data integrity strategy and implementation, descriptive statistics for pharma, lifecycle process validation, and site master planning. In addition, an extensive Expo will showcase more than 300 companies offering advanced technologies and services.

To learn more about this event and to register, visit http://www.ISPE.org/Conferences/2018-Annual-Meeting-Expo.

About ISPE
The International Society for Pharmaceutical Engineering (ISPE) is the world’s largest not-for-profit association serving its members through leading scientific, technical, and regulatory advancement across the entire pharmaceutical lifecycle. The 18,000 members of ISPE are building solutions in the development and manufacture of safe, effective pharmaceutical and biologic medicines, and medical delivery devices in more than 90 countries around the world. Founded in 1980, ISPE has its worldwide headquarters in Bethesda, Maryland USA, and its operations center in Tampa, Florida USA. Visit http://www.ISPE.org for more information.

For more information contact:
Maria Robertson
Senior Director, Marketing Communications
International Society for Pharmaceutical Engineering (ISPE)
Tel: +1-301-364-9207
Email: [email protected]

Powered by WPeMatico